Nanomedicine

Nanomedicine, the fusion of nanotechnology and medicine, spans a spectrum from utilizing nanomaterials and biological devices to exploring nanoelectronic biosensors and the potential applications of molecular nanotechnology, such as biological machines. Ongoing challenges in nanomedicine include grappling with the toxicity and environmental impact of nanoscale materials.

The field envisions providing a valuable array of research tools and clinically beneficial devices in the near future. Forecasts from the National Nanotechnology Initiative anticipate novel commercial applications in the pharmaceutical industry, encompassing advanced drug delivery systems, innovative therapies, and cutting-edge in vivo imaging.

With around 80 marketed products already in nanomedicine, covering areas like nano-delivery, pharmaceuticals, medical imaging, diagnostics, and biomaterials, the field addresses the pressing challenges posed by an aging population. Nanomedicine emerges as a crucial contributor to enhanced and cost-effective healthcare, playing a pivotal role in making medicines and treatments universally available and affordable.

Committee Members
Speaker at Drug Delivery Events - Vladlen Slepak

Vladlen Slepak

University of Miami Miller School of Medicine, United States
Speaker at Drug Delivery Events - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Huiqin Yang

Huiqin Yang

ICON Clinical Research Ltd, United Kingdom

Submit your abstract Today

Youtube
Watsapp